Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage

Cerebrovascular Diseases
Yukito Shinohara

Abstract

We have previously reported that the phosphodiesterase inhibitor cilostazol, an antiplatelet agent, is effective and safe for secondary prevention of recurrent cerebral infarction (Cilostazol Stroke Prevention Study; CSPS). We now report the efficacy of this drug in the prevention of pneumonia in the chronic stage of cerebral infarction as a part of our CSPS subgroup analysis. The analysis was conducted in 1,049 subjects; 524 in the cilostazol group and 525 in the placebo group. The incidences of pneumonia during the 3.3-year follow-up were 2.86% (15 in 525 patients) in the placebo group and 0.57% (3 in 524 patients) in the cilostazol group, with a significant reduction in the cilostazol group. The rates of complications and pneumonia risk factors showed no difference between the two groups. We conclude that the administration of cilostazol to patients with cerebral infarction in the chronic stage does not only reduce the recurrence of infarction but also the incidence of pneumonia at least in Japanese patients.

References

Oct 6, 1998·Lancet·K SekizawaH Sasaki
Dec 24, 1998·Lancet·T AraiY Kashiki
Jun 3, 2000·Stroke; a Journal of Cerebral Circulation·P LanghorneG Murray
May 31, 2001·Journal of the American Geriatrics Society·M YamayaH Sasaki
Mar 3, 2004·American Journal of Respiratory and Critical Care Medicine·Takayoshi OhkuboUNKNOWN Perindopril Protection Against Recurrent Stroke Sutdy Collaborative Group
Jul 1, 2000·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·F GotohY Ohashi

❮ Previous
Next ❯

Citations

Dec 17, 2008·Current Neurology and Neuroscience Reports·Georgios ManousakisRoss L Levine
Feb 5, 2014·Biosensors & Bioelectronics·Guillaume SuárezMichael Riediker
Aug 2, 2011·Internal Medicine·Kazutoshi NishiyamaYoshiaki Shiokawa
Jul 16, 2014·European Heart Journal·Giuseppe PattiUNKNOWN Working Group on Thrombosis of the Italian Society of Cardiology
Aug 11, 2012·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Aiko OsawaNorio Tanahashi
Feb 7, 2015·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Tatsushi Kamiya, Yasuo Katayama
May 11, 2007·Acta Neurologica Scandinavica·J Kwan, P Hand
May 12, 2011·International Journal of Stroke : Official Journal of the International Stroke Society·Jong S Kim, Yukito Shinohara
Mar 24, 2016·International Journal of Stroke : Official Journal of the International Stroke Society·David L CohenPhilip M Bath
Aug 14, 2009·Expert Review of Neurotherapeutics·Shinji Teramoto
Sep 14, 2019·Expert Review of Clinical Pharmacology·Abraham E Rodriguez, Marcos I Restrepo
Sep 30, 2020·PloS One·Masahiro NakamoriShinichi Wakabayashi
May 4, 2016·PloS One·Shiro AokiUNKNOWN Hiroshima University Hospital Stroke Swallowing Team
Sep 7, 2018·Journal of General and Family Medicine·Tsuneaki KenzakaShinsuke Yahata
Apr 11, 2018·Pneumonia·Hirotaka NakashimaMasafumi Kuzuya
Mar 10, 2017·International Journal of Molecular Sciences·Takashi AsanoMari Okazaki
Jan 9, 2021·International Immunopharmacology·Nadia Alice Vieira MottaFernanda Carla Ferreira de Brito
Oct 12, 2007·Medicina clínica·Jordi AlmirallPere Clavé

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.